Skip to content
Homepage
Author:
Bio Usawa Inc
Posted Date:
June 15, 2026
Bio Usawa Appoints Dr. Aida Habtezion, Former Chief Medical Officer at Pfizer, to its Board of Directors
Bio Usawa Inc
June 15, 2026
Defeating the “Cold Chain” Barrier: Bio Usawa and Nanoly Bioscience Announce Strategic $500 Million Licensing Agreement for Breakthrough DynaShield™ Technology
Bio Usawa Inc
February 17, 2026
